Anti-Infective

NEWTOWN, Pa. July 26, 2011 - The global market for anti-infectives drugs is anticipated to exceed $100 billion by 2015, driven by significant unmet needs, growing patient populations, better diagnostics, and innovative new drugs. Because viruses mutate rapidly and acquire drug resistance, the antiviral pipeline needs to be continuously replenished with better treatments.